Cancer (Oncology) Trials

Return to Cancer Search

A Phase 1-2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-C19 in Pediatric and Adolescent Subjects with Philadelphia Chromosome-Negative Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL)

IRB/UVa Tracking #: 19087

Principal Investigator: Daniel Lee

Contact: Jessica Pritchard

Tel: 434-924-0370

Email: jep4n@virginia.edu